A Mother’s Decision: The First Shot, Hepatitis B

A Mother’s Decision: The First Shot, Hepatitis B -Health & Beauty Informations. This article, entitled A Mother’s Decision: The First Shot, Hepatitis B, we have prepared this article carefully for you so you can retrieve information therein. Hopefully you understand the contents of this article that we put under the category health, well, happy reading.

Title : A Mother’s Decision: The First Shot, Hepatitis B
link : A Mother’s Decision: The First Shot, Hepatitis B

Baca juga


A Mother’s Decision: The First Shot, Hepatitis B

The day has come and your little bundle is here. The wonder of it is overwhelming: this man came from two cells, within you, and despite the last two days feeling like a year each, all this happened in nine months, without you lot, but waiting. If you are in a hospital, your baby is likely to be taken that the entry into the world, and subjected to all kinds of empirical interventions to control the damage for all its weaknesses and dysfunctions lurking - antibiotics in eyes, vitamin K in your blood, a good cleaning with some 1, 4-dioxane and baby wash containing formaldehyde, and since 1991, the vaccine against hepatitis B.

What is that? Why does my baby need?

According to CDC , everyone needs it. As we understand, this is a transmissible infection that can, in percentages discussed, progress to cirrhosis, liver cancer and death. Populations at risk are those having unprotected sex, intravenous drug use (not most babies!), The transfused, or contact with infected blood with a party. Of infected adults, 90-95% of eliminating the virus on their own, without intervention, according to my textbook of medical school, principals Harrisons of Internal Medicine. Concern about childhood contraction of the virus is that the immature neonatal immune system "allows" for the virus to hang up chronically 90% of cases . Then in the 2nd or 3rd decade of life, most of these infected infants enter the "phase HBeAg +" on those who may be at risk of escalating cirrhosis, progressive liver damage and cancer. Viral replication, virus genotype ( are 8 known), the damage of liver cells as measured by enzymes, and the characteristics of the host immune response cause the movement through different phases the chronic infection quite variable. Therefore, in those mothers with active infection as determined by testing viral DNA and antigen / antibody, the transmission management baby is a pressing concern. I will discuss how we may be failing to address this pressing concern in an effective manner.

But what about the rest of babies born uninfected mothers? His newborn, outside the womb, the baby needs this injection of recombinant viral DNA engineered inserted in a yeast cell, as they are reportedly easy to "capture" at that point, and to ensure compliance ( unlike adults increased risk); However, prevention of vertical transmission from mother to child is considered as the main indication (despite the ease of assessing whether the mother is infected reality), because it is a primary source of the disease burden.

Does this work?

Much is unknown and difficult to quantify the effects of the vaccine including the production of antibodies, if it occurs, can be very short and certainly can not take children in their teenage years when they may be at greater risk of behavior for contraction. Assessments pre prevalence and subsequent introduction of the vaccine appears to have suggested that vaccination was responsible for a decrease of chronic hepatitis B infection in children age 6-19 , but these documents use levels blood antigen and surface antigen HBcore instead of polymerase chain reaction tests to viral DNA . What if all these data were invalidated by the outdated evidence that does not actually identify chronic infection?

A paper that illuminates , just published in Journal of Viral Hepatitis can shed light on the true results of this approach and founded on a misconception of the virus and its interaction with our immune system. This trial evaluated for the infection status of 259 pregnant women with hepatitis B to see the presence of viral DNA, viral antigens called HBeAg and HBsAg, indicating that the body is infected actively, and antibodies against both antigens.

all babies in the study were vaccinated in 0,6,10 and 14 weeks, so that, as has been the case in all studies of efficacy and safety of vaccines, no naturalist placebo group. A group of these infants received hepatitis immunoglobulin (HBIG) derived from infected adults actively, and the other group did not, and infection levels were evaluated over a period of two years. deeper they looked in previous studies, as observed the presence of viral DNA in these babies with time, not only the production of antibodies or "immune response"

This is what they found:.
"the results of this large prospective longitudinal study show that 42% of babies born to mothers HBsAg positive develop occult HBV, which is not prevented by the administration of the vaccine recombinant HBV for the newborn."
What does this mean?

The implication of this is that the immune response to the vaccine, which is advertised as "proof of efficacy" in fact did not influence the infectious statistical results. Only exposure to active maternal infection at birth correlates with future results. Give HBIG babies (no vaccine) may have suppressed the infection manifested in some cases, but merely sent it underground, something called covert infection, so that 49% of infected infants remained after these interventions

Contrary to the claims (often funded by industry: refs 5 to 9 ; ref 11 ). of the cited studies claiming 85-95% efficacy of the vaccine alone and in combination with HBIG in preventing acute and chronic infection in babies born to infected mothers, this study found that, there was just a baby will develop a chronic infection, but the type of infection that developed They did not prompt response expected antibodies and would likely burn there chronically without routine screening even when these people can get to donate blood, organ donation, and sex.

no studies claiming historical efficacy of the vaccine have never really tested for the persistent presence of viral DNA. In fact, most have assessed only by the presence of antibodies.

This covert infection theory developed as a result of the "immune booster" of these treatments, leading to viral mutations circumventing the host, and result in the failure to produce detectable antibodies. These mutations accumulate in vaccinated children and can be transmitted from mother to child.

What this means is that the current practice, as applied to the group of the right people for intervention (newborns of infected mothers who hoped to protect), it is not effective in preventing infection and may contribute to mutations in the virus that allows for covert infection.

by so if it works even 1% more than a coin to prevent infection, why not?

Because it is a toxic exposure is unknown and unpredictable effects. It never has been adequately studied in humans (true placebo control), and what we see in the reports based on the population is 443.093 adverse events (headache, irritability, extreme fatigue, brain swelling, seizures, rheumatoid arthritis , optic neuritis, multiple sclerosis, lupus, Guillain-Barre syndrome (GBS) and neuropathy) have been recorded including> 1500 deaths, often labeled as a syndrome of sudden infant death syndrome. NVIC discussed:
A landmark report in 1994 published by the Institute of Medicine of the National Academy of Sciences, reviewed the medical literature for evidence that vaccines, including Hepatitis B vaccine can cause a variety of problems of immunological and neurological health. An independent committee of medical experts concluded that there were not controlled observational studies or controlled clinical trials on the vaccine against hepatitis B, either before or after obtaining the license to scientifically evaluate reports that the vaccine hepatitis B can cause the syndrome of sudden infant death case; Guillain-Barre syndrome (GBS) and other central demyelinating diseases including transverse myelitis, optic neuritis and multiple sclerosis; and immune system dysfunction including chronic arthritis.
The Institute of Medicine considers that causal relationships can be established between vaccination and adverse events due to lack of data. This data seems essential to formally initiate accumulation.

Why is so toxic?

This fact:
recombinant vaccine adsorbed hepatitis B was prepared from cells of Chinese hamster ovary transformed, and is a liquid product containing the surface antigen of hepatitis B that is rendered insoluble by adding aluminum salt.
Y makes ...
Hepatitis B vaccine has a broad spectrum of activity, and 144 genes with different functions, including metabolism and inflammation were expressed differentially after vaccination.
As someone interested in the role of inflammation in chronic diseases, including mental illness, heart disease, cancer and autoimmunity, this study mouse cited concerns me that showed the cumulative inflammatory stimulation and damage with exposure to vaccine lasting after the first day of injection.

who cares about aluminum?

Aluminum is activated microglia in the brain and is strongly linked to Alzheimer's, Parkinson's disease and autoimmune disorders . This is a known neurotoxin potent immune stimulating - added because the immune system of the newborn is built not answer. This has been referred to as the anti-inflammatory phenotype and speaks to the powerful interaction between a baby, his mother's milk, and priming of the immune system in the first 2 years of life. Several exploratory analyzes have argued for a causal role for aluminum in the incidence of autism including one by Lucija Tomeljenovic and Shaw and MIT researcher Stephanie Seneff established :
"mentions of autism in VAERS increased steadily at the end of the last century, during a period when the mercury is being phased out, while the adjuvant aluminum load increases. the use of techniques ratio standard logarithmic likelihood, we identified several signs and symptoms that are significantly more common in reports of vaccine after 2000, including cellulitis, convulsions, depression, fatigue, pain and death, which was also significantly associated with vaccines contain aluminum. we suggest that children with a diagnosis of autism are especially vulnerable to toxic metals such as aluminum and mercury due to insufficient serum sulfate and glutathione. "
Other study found that children who received the vaccine Engerix B Hepatitis B were 74% more likely to develop" Central demyelination nervous system inflammatory "that children who received the vaccine and 177% more likely to develop multiple sclerosis.

stimulate the immune response in the presence of a toxic or "adjuvant" additive such as a metal, is also likely to contribute to autoimmune phenomenon according to current immunological theories I discuss here and conceptually it corroborated by similarity between HBV amino acid structure and human proteins .

The only study in primates made with a control group he vaccinated showed concerningly delayed acquisition of reflexes neurodevelopmental thimerosal (ethylmercury forming preservative) Hep B group (especially those with low birth weight and gestational age) vaccinated with respect to the unexposed group. Studies such as this, along with those who, like this determining a 9x greater risk for receiving special education services to children who received the vaccine series pre-2001 Hep B, and one that suggested one 3- fold increased risk of autism diagnosis likely led to the removal of thimerosal from the product in 2001. the vaccine containing thimerosal-was on the market for 19 years before this change (and still it is an ingredient of the vaccine against influenza and tetanus), which can pose problems for some for the delay in the remediation of the dangers associated with these products. These dangers are learned from post-hoc, in the field, after many children have paid the price of inadequate placebo-controlled, long-term study.

What to do?

As a physician, who do everything possible to support healthy immunity in my pregnant patients. I do it through diet, minimizing environmental exposure by promoting exercise and alleviating stress response through meditation. There is much to learn about our immune system and particularly about their interaction with environmental factors and other systems in the body, including neuroendocrine. Until we know more, we go carefully, lest "first harm" - something doctors pledged to do

Source:. greenmedinfo.com

"A Mother’s Decision: The First Shot, Hepatitis B", article source: riseearth.com


Thanks for Reading A Mother’s Decision: The First Shot, Hepatitis B

Thank you for reading this A Mother’s Decision: The First Shot, Hepatitis B, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article A Mother’s Decision: The First Shot, Hepatitis B Url Address https://healthnbeautyarticles.blogspot.com/2014/01/a-mothers-decision-first-shot-hepatitis.html

0 Response to "A Mother’s Decision: The First Shot, Hepatitis B"

Post a Comment